Choosing a Time Horizon in Cost and Cost-effectiveness Analyses.
Publication
, Journal Article
Basu, A; Maciejewski, ML
Published in: JAMA
March 19, 2019
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
March 19, 2019
Volume
321
Issue
11
Start / End Page
1096 / 1097
Location
United States
Related Subject Headings
- Quality-Adjusted Life Years
- Models, Economic
- Macular Degeneration
- Humans
- General & Internal Medicine
- Cost-Benefit Analysis
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Basu, A., & Maciejewski, M. L. (2019). Choosing a Time Horizon in Cost and Cost-effectiveness Analyses. JAMA, 321(11), 1096–1097. https://doi.org/10.1001/jama.2019.1153
Basu, Anirban, and Matthew L. Maciejewski. “Choosing a Time Horizon in Cost and Cost-effectiveness Analyses.” JAMA 321, no. 11 (March 19, 2019): 1096–97. https://doi.org/10.1001/jama.2019.1153.
Basu A, Maciejewski ML. Choosing a Time Horizon in Cost and Cost-effectiveness Analyses. JAMA. 2019 Mar 19;321(11):1096–7.
Basu, Anirban, and Matthew L. Maciejewski. “Choosing a Time Horizon in Cost and Cost-effectiveness Analyses.” JAMA, vol. 321, no. 11, Mar. 2019, pp. 1096–97. Pubmed, doi:10.1001/jama.2019.1153.
Basu A, Maciejewski ML. Choosing a Time Horizon in Cost and Cost-effectiveness Analyses. JAMA. 2019 Mar 19;321(11):1096–1097.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
March 19, 2019
Volume
321
Issue
11
Start / End Page
1096 / 1097
Location
United States
Related Subject Headings
- Quality-Adjusted Life Years
- Models, Economic
- Macular Degeneration
- Humans
- General & Internal Medicine
- Cost-Benefit Analysis
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences